1. Home
  2. JD vs ILMN Comparison

JD vs ILMN Comparison

Compare JD & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JD.com Inc.

JD

JD.com Inc.

HOLD

Current Price

$26.49

Market Cap

39.2B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$270.57

Market Cap

37.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JD
ILMN
Founded
2006
1998
Country
China
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.2B
37.0B
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
JD
ILMN
Price
$26.49
$270.57
Analyst Decision
Strong Buy
Hold
Analyst Count
11
17
Target Price
$39.27
★ $124.24
AVG Volume (30 Days)
★ 5.4M
2.2M
Earning Date
05-12-2026
04-30-2026
Dividend Yield
★ 3.37%
N/A
EPS Growth
N/A
★ 170.87
EPS
N/A
★ 2.22
Revenue
N/A
★ $4,343,000,000.00
Revenue This Year
$8.17
$6.47
Revenue Next Year
$6.01
$5.58
P/E Ratio
★ $9.17
$123.38
Revenue Growth
★ N/A
N/A
52 Week Low
$24.51
$88.00
52 Week High
$36.86
$277.95

Technical Indicators

Market Signals
Indicator
JD
ILMN
Relative Strength Index (RSI) 33.32 77.89
Support Level $24.53 $116.43
Resistance Level $27.63 N/A
Average True Range (ATR) 0.39 11.84
MACD 0.04 5.39
Stochastic Oscillator 8.11 97.23

Price Performance

Historical Comparison
JD
ILMN

About JD JD.com Inc.

JD.com is the third-largest Chinese e-commerce platform by gross merchandise volume in 2025. It offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace, and omnichannel businesses.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: